4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News
March 15, 2010 03:03 am US/Eastern
Search
Dynamic quotes   
On
 | Off

4-Traders Homepage  >  Shares  >  Euronext Paris  >  SANOFI-AVENTIS   SAN   FR0000120578

Real time Streaming quotes -

SANOFI-AVENTIS (SAN)

Real-time Quote. Real-time Tradegate - 03/12 03:59:59 pm
55.361 EUR   -0.52%
03/11SANOFI-AVENTIS: Successfully Completes the Acquisition of Chatte..
03/09SANOFI-AVENTIS: and Merck to create a Global Leader in Animal He..
03/04SANOFI-AVENTIS: Cabazitaxel Increased Survival for Patients with..
SummaryQuotesChart AnalysisNewsCompanyFundamentalsConsensus
NewsRSS News

SANOFI-AVENTIS : Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l'Autorité des Marchés Financiers

12/21/2009 | 11:20 am


PR Newswire/Les Echos/

Information concerning the total number of voting rights and shares, provided
pursuant to article L. 233-8 II of the Code de commerce (the French Commercial
Code) and article 223-16 of the Règlement général de l'Autorité des Marchés
Financiers (Regulation of the French stock market authority)

sanofi-aventis
a French société anonyme with a registered share capital of 2,631,050,926 EUR
Registered office : 174, avenue de France - 75013 Paris - France
Registered at the Paris Commercial and Companies Registry
under number 395 030 844

Date Total number of Total number of
outstanding shares voting rights *
November 30, 2009 1,316,452,799 1,556,331,074

* : Pursuant to article 223-11 of the Règlement général de l'Autorité des
Marchés Financiers.

This information is also available on the internet website of sanofi-aventis
under " Regulated Information in France ":

http:
//en.sanofi-aventis.com/investors/regulatedinfofrance/regulatedinfofrance.asp

Investor Relations Department
Europe Tel: + 33 1 53 77 45 45 US Tel: + 1 908 981 5560
e-mail: IR@sanofi-aventis.com

Media Relations Department
Tel: + 33 1 53 77 44 50
e-mail: MR@sanofi-aventis.com

The content and accuracy of news releases published on this site and/or
distributed by PR Newswire or its partners are the sole responsibility of the
originating company or organisation. Whilst every effort is made to ensure the
accuracy of our services, such releases are not actively monitored or reviewed
by PR Newswire or its partners and under no circumstances shall PR Newswire or
its partners be liable for any loss or damage resulting from the use of such
information. All information should be checked prior to publication.

Latest news on SANOFI-AVENTIS
03/11Successfully Completes the Acquisition of Chattem, Inc.
03/09And Merck to create a Global Leader in Animal Health
03/04Cabazitaxel Increased Survival for Patients with Advanced Hormone-Refr..
03/02Board of Directors of sanofi-aventis
02/26Information concerning the total number of voting rights and shares, p..
02/19Sanofi Pasteur's A(H1N1) Vaccine HUMENZA®* Recommended by European Med..
02/18Strengthens Commitment to Research in France through Partnership with ..
02/15My child matters Supports Seven New Childhood Cancer Care Projects
02/09Successfully Completes Tender Offer for Chattem, Inc.
01/29Signs Agreements to Establish New Consumer Healthcare Joint Venture in..
Price share SANOFI-AVENTIS (FRANCE), Source for Financial Market Quotes, Charts, Technical Analysis and Consensus. Stock market quotes including the latest stock price , stock market quote for the NASDAQ 100, news and fundamental investing data and price charts. The easy way to get information on stocks, currencies, indexes, commodities , certicates, and Warrants. Contact us ¤ Site map
Quotes are delayed 15 minutes for Nasdaq, Nyse and Euronext. Dow Jones indexes from Dow Jones & Company and Nasdaq indexes are 15 minutes delayed. CAC 40, Forex and Tradegate exchange are in real-time. Others exchanges are in end of day. Data are provided by Interactive Data - Tijd Beursmedia.
Copyright ©  2001 - 2010 Surperformance SAS /